Erasca Inc. Common Stock vs VanEck Uranium & Nuclear ETF — how do they compare? Erasca Inc. Common Stock trades at $15.93 (market cap $5.40B), while VanEck Uranium & Nuclear ETF trades at $103.28 (market cap $3.51B). The key difference: Erasca Inc. Common Stock is the larger of the two by market cap, and Erasca Inc. Common Stock is trading nearer its 52-week high, VanEck Uranium & Nuclear ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Erasca Inc. Common Stock for 0 Days and VanEck Uranium & Nuclear ETF for 7 Days on average.
| ERAS | NLR | |
|---|---|---|
Market Cap | $5.40B | $3.51B |
Volume | 9,533,185 | 414,516 |
Sector | Health | Sector/Thematic |
52-Week High | $22.47 | $164.37 |
52-Week Low | $2.20 | $102.38 |
Typical Hold Time | 0 Days | 7 Days |
Enterprise Value | $5.18B | — |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Erasca is a biotechnology company developing precision medicines for cancer. Its programs target genetic drivers of tumor growth.
Read more on ERAS →VanEck Uranium and Nuclear ETF seeks exposure to companies involved in uranium mining and the nuclear power industry. Its holdings may include miners, utilities, reactor-related companies, and nuclear equipment or service providers.
Read more on NLR →